Background and Aims
Chronic respiratory diseases are prominent causes of morbidity worldwide that impose significant social and economic burdens on individuals and communities. Pulmonary rehabilitation is one of the main aspects of medical rehabilitation. Nowadays, mobile health apps deliver pulmonary rehabilitation support via smartphones. This article presents a systematic review of the literature on mâHealth apps used in respiration disorders rehabilitation.
Methods
A systematic search was performed on MEDLINE (through PubMed), Web of Science, and Scopus in May 2021 without any date limitation. This study was using a combination of keywords and MeSH terms associated with pulmonary rehabilitation. Relevant studies were selected by two independents and were categorized studies results. The inclusion criterion was mâHealth apps for pulmonary rehabilitation and exclusion criteria mobileâbased interventions, by voice call or short message service and cardiopulmonary articles.
Results
Searching scientific databases yielded 161 relevant articles. Then, 27 articles were included in the study with a complete evaluation of the articles. Sixty percent of them were related to patients with chronic obstructive pulmonary disease (COPD). Rehabilitation aiming to improve the quality of life, promote selfâmanagement, encourage physical activity, and reduce the symptoms as the most common goals of pulmonary rehabilitation using mâHealth apps; 89% of these studies showed that mâHealth apps can be effective in improving pulmonary rehabilitation. In addition, 37% of studies reported high usability and acceptance. However, the results of some studies show that adherence to apps decreases in the long run.
Conclusion
Our study shows that mâHealth pulmonary rehabilitation apps are effective in improving the quality of life, selfâmanagement, and physical activity. According to the results, it seems that using the mâHealth apps for pulmonary rehabilitation can be useful in the COVIDâ19 pandemic and help reduce respiratory disorders in patients with COVIDâ19 disease.